|
|
||||||||
1From the Department of Vision Science, University of Alabama at Birmingham, Birmingham, Alabama; and the 2Department of Ophthalmology, University of Alabama School of Medicine, Birmingham, Alabama.
PURPOSE. The goal of this study was to determine the influence, if any, of the insulin-like growth factors (IGFs) on retinal pigment epithelial (RPE) cell tractional force generation and the contributions of vitreous insulin-like growth factorbinding proteins (IGFBPs) toward control of growth factor activity.
METHODS. IGF effects on RPE were evaluated in tissue culture assays that involved incubation on three-dimensional collagen matrices with responses measured as progressive reduction in matrix thickness. IGFBP effects were evaluated by using the same system, exposing cells to a nonIGFBP-binding growth factor analogue (R3IGF-I) or IGFBPs alone or in combination with native growth factors.
RESULTS. RPE cells generated tractional forces in response to IGF-I and -II with IGF-I being the more potent stimulus. Differential RPE responses to R3IGF-I reflected minor amounts of endogenous IGFBP production. IGFBP-2, -3, and -5 were effective inhibitors of both ligands, whereas IGFBP-6 reduced cell responses to IGF-II only. IGFBP-direct effects on the cells were binding-proteinspecific, in that IGFBP-1 had detectable stimulatory effects, and IGFBP-3, -4, -5, and -6 inhibited RPE responses.
CONCLUSIONS. IGF-I and -II are potent promoters of RPE cell tractional force generation in vitro. The effects of the six high-affinity IGFBPs on RPE responses are generally inhibitory and protein-specific. IGF ligands and binding proteins are known to be present in the vitreous, the environment that drives RPE responses in proliferative vitreoretinopathy (PVR), suggesting that the IGF system plays a potentially important role in the pathophysiology of this fibrocontractive disease.
This article has been cited by other articles:
![]() |
S. He, Y. Chen, R. Khankan, E. Barron, R. Burton, D. Zhu, S. J. Ryan, N. Oliver, and D. R. Hinton Connective Tissue Growth Factor as a Mediator of Intraocular Fibrosis Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 4078 - 4088. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |